13 completed, 5 terminated, 5 unknown, 2 active not recruiting. 27 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 27 | Completed 13, Terminated 5, Unknown 5, Active not recruiting 2, Recruiting 1, Withdrawn 1 |
Follow Deep Vein Thrombosis: new trials by email Literature Review of Deep Vein Thrombosis trials Research Report on Deep Vein Thrombosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Total hIp or Total kNee replaCemenT Short duration prophylaxis, Higher intensity and longer duration prophylaxis, Control - Venous Thromboembolism, Venous Thromboses | Phase 4 | Recruiting | Leiden University Medical Center | 10078 | 2024-11-11 | 2026-09-08 |
| Therapeutic Initial Heparin Dosing for Patients With Clots or Certain Heart Conditions Admitted to the Hospital Initial Heparin Dose Modification - Pulmonary Embolism, Deep Vein Thrombosis | Phase 4 | Active not recruiting | Inova Health Care Services | 145 | 2023-09-20 | 2025-11-26 |
| The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE) Dabigatran Etexilate Oral Capsule, Rivaroxaban Oral Tablet, Edoxaban Oral Tablet - Deep Vein Thrombosis, Pulmonary Embolism | Phase 4 | Active not recruiting | Herlev and Gentofte Hospital | 5000 | 2023-04-01 | 2025-05-15 |
| Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome tinzaparin, Rivaroxaban - Deep Vein Thrombosis, Post Thrombotic Syndrome | Phase 4 | Terminated | Sunnybrook Health Sciences Centre | 9 | 2021-11-15 | 2024-04-04 |
| Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism Apixaban 2.5 MG, Placebo oral tablet - Deep Vein Thrombosis, Pulmonary Embolism | Phase 4 | Completed | Brigham and Women's Hospital | 600 | 2021-03-01 | 2025-11-14 |
| Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19 Enoxaparin - COVID, Thrombosis | Phase 4 | Completed | Central Hospital, Nancy, France | 1000 | 2020-05-13 | 2023-08-07 |
| Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxaban Enoxaparin 40 milligram/0.4 milliliter Injectable Syringe 0.4 milliliters, Rivaroxaban 10 milligram Oral Tablet - Deep Vein Thrombosis, Venous Thromboembolism | Phase 4 | Unknown | Florida Orthopaedic Institute | 128 | 2020-01-13 | 2020-01-18 |
| Calf Deep Vein Thrombosis Treatment Trial Apixaban, Placebo - Deep Vein Thrombosis | Phase 4 | Terminated | Mayo Clinic | 5 | 2019-02-19 | 2020-03-25 |
| Rivaroxaban With Diosmin in Long-term Treatment of Deep Vein Thrombosis Rivaroxaban, Diosmin, compression stockings - Deep Vein Thrombosis, Postthrombotic Syndrome | Phase 4 | Completed | Pirogov Russian National Research Medical University | 90 | 2017-12-20 | 2021-02-04 |
| Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis apixaban - Deep Venous Thrombosis, Upper Extremity Deep Venous Thrombosis | Phase 4 | Terminated | Intermountain Health Care, Inc. | 52 | 2017-02-22 | 2023-09-28 |
| Safety of Topical Tranexamic Acid in Total Joint Arthroplasty in High Risk Patients Tranexamic Acid, Normal saline - Pulmonary Embolism, Deep Vein Thrombosis | Phase 4 | Withdrawn | Albert Einstein College of Medicine | 2016-02-01 | 2018-05-31 | |
| Treatment of Chronic Deep Vein Thrombosis (DVT) and Post-Thrombotic Syndrome (PTS) With the EkoSonic® Endovascular System EkoSonic® Endovascular System, Alteplase - Deep Vein Thrombosis, Post-thrombotic Syndrome | Phase 4 | Completed | Boston Scientific Corporation | 81 | 2014-07-10 | 2021-07-19 |
| Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin 5000 Units unfractionated Heparin Q 8 hr, 30mg enoxaparin Q12 hr - Venous Thromboembolic Disease, Deep Vein Thrombosis | Phase 4 | Completed | Scripps Health | 495 | 2012-11-01 | 2016-07-18 |
| Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients Genotype-guided warfarin dosing, Non-genotype guided warfarin dosing - Atrial Fibrillation, Deep Vein Thrombosis | Phase 4 | Unknown | Chinese PLA General Hospital | 500 | 2012-06-01 | 2013-10-09 |
| Echo-Doppler Assessment of the Occurrence of Asymptomatic DVT in Orthopedic Replacement Surgery Under Enoxaparin Enoxaparin - Deep Vein Thrombosis, Venous Thrombosis | Phase 4 | Completed | Les Laboratoires des Médicaments Stériles | 153 | 2011-03-01 | 2015-11-03 |
| Rosuvastatin for Preventing Deep Vein Thrombosis Rosuvastatin 20mg/d for 14days, enoxaparin only - Deep Vein Thrombosis, Venous | Phase 4 | Unknown | Hallym University Medical Center | 180 | 2009-10-01 | 2011-10-05 |
| Safety and Efficacy Study of OmniWave Endovascular System to Treat Deep Vein Thrombosis OmniWave Endovascular System - Deep Vein Thrombosis | Phase 4 | Unknown | OmniSonics Medical Technologies, Inc. | 50 | 2008-03-01 | 2008-03-21 |
| Comparison of Warfarin Dosing Using Decision Model Versus Pharmacogenetic Algorithm Warfarin Dose based on pharmacogenetics - Atrial Fibrillation, Pulmonary Embolism | Phase 4 | Completed | Creighton University | 102 | 2006-08-01 | 2012-12-11 |
| Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis innohep®, Heparin - Deep Vein Thrombosis | Phase 4 | Completed | LEO Pharma | 541 | 2005-12-01 | 2025-03-06 |
| The Effect of Enoxaparin Sodium on the Incidence of Deep Vein Thrombosis Following Electrophysiology Studies and Radiofrequency Ablation. Clexane - Deep Vein Thrombosis | Phase 4 | Terminated | Melbourne Health | 35 | 2005-08-01 | 2013-05-30 |
Showing 20 of 27. Sign in to see all of them.
Venous Thrombosis (27) · Pulmonary Embolism (12) · Venous Thromboembolism (6) · Thrombosis (4) · Atrial Fibrillation (3) · Postthrombotic Syndrome (3) · Heart Valve Diseases (1) · Myocardial Infarction (1) · Neoplasms (1) · Peripheral Vascular Diseases (1) · Recurrence (1) · Stroke (1) · Thromboembolism (1) · Tibial Fractures (1) · Vitamin K-Dependent Clotting Factors, Combined Deficiency Of, Type 2 (1)
Cardiovascular Diseases (27) · Embolism and Thrombosis (27) · Vascular Diseases (27) · Thrombosis (23) · Embolism (12) · Lung Diseases (12) · Respiratory Tract Diseases (12) · Thromboembolism (6) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Heart Diseases (4) · Arrhythmias, Cardiac (3) · Venous Insufficiency (3) · Brain Diseases (1) · Central Nervous System Diseases (1)
Enoxaparin (5) · Rivaroxaban (4) · apixaban (4) · Dalteparin (3) · Heparin, Low-Molecular-Weight (3) · Tinzaparin (3) · Warfarin (2) · Dabigatran (1) · Diosmin (1) · Heparin (1) · Nadroparin (1) · Rosuvastatin Calcium (1) · Saline Solution (1) · Stockings, Compression (1) · Tissue Plasminogen Activator (1)
Azienda Ospedaliera Universitaria Policlinico (3) · Sunnybrook Health Sciences Centre (2) · Albert Einstein College of Medicine (1) · Boston Scientific Corporation (1) · Brigham and Women's Hospital (1) · British Thoracic Society (1) · Central Hospital, Nancy, France (1) · Chinese PLA General Hospital (1) · Creighton University (1) · Florida Orthopaedic Institute (1) · Hallym University Medical Center (1) · Herlev and Gentofte Hospital (1) · IRCCS Azienda Ospedaliero-Universitaria di Bologna (1) · Inova Health Care Services (1) · Intermountain Health Care, Inc. (1)
United States (7) · Italy (3) · Canada (2) · France (2) · Spain (2) · Australia (1) · Bulgaria (1) · China (1) · Croatia (1) · Czechia (1) · Denmark (1) · Germany (1) · Netherlands (1) · Poland (1) · Romania (1)
Sergio Siragusa, MD (3) · Abdelaziz Zarrouk, MD (1) · Alain Leizorovicz, MD (1) · Aziz Sheikh, MD,FRCGP (1) · Banne Nemeth, dr (1) · Christopher J. Destache, Pharm. D. (1) · El Mehdi Siaghy (1) · Gunnar H Gislason, MD, PhD (1) · Hassan Mir, MD (1) · Ilya Schastlivtsev, PhD (1) · Jean-Philippe Galanaud, MD (1) · John Aruny, MD (1) · Mark Garcia, MD (1) · Mustapha Azaiz, MD (1)
PMID 17065639, PMID 17289685, PMID 18497320, PMID 20352167, PMID 20553388, PMID 21477846, PMID 21684353, PMID 21953853, PMID 23306310, PMID 23629822, PMID 25267738, PMID 25900749, PMID 31983322, PMID 33201130, PMID 33502773, PMID 35244208, PMID 36399673, PMID 37350990, PMID 37907305, PMID 40888734, PMID 41057196
2023 (1)